OSI Pharmaceuticals, Inc. (OSIP) to Divest Eye-Disease Program
7/27/2007 10:58:19 AM
More...
|
The Day In Review: OSI Pharmaceuticals, Inc. (OSIP) Gives Up On Macugen
11/7/2006 5:49:53 PM
More...
|
Lux Biosciences Appoints To Board Of Directors David Guyer, SVLS Venture Partner And Former CEO Of Eyetech Pharmaceuticals, Inc. (EYET)
7/11/2006 12:55:45 PM
More...
|
OSI Pharmaceuticals, Inc. (OSIP) To Host Conference Call To Discuss (OSI) Eyetech Pharmaceuticals, Inc. (EYET) Integration Strategy
11/16/2005 6:20:30 PM
More...
|
OSI Pharmaceuticals, Inc. (OSIP) Completes Its Acquisition Of Eyetech Pharmaceuticals, Inc. (EYET)
11/14/2005 2:24:38 PM
More...
|
OSI Pharmaceuticals, Inc. (OSIP) Updates Status Of Pending Acquisition Of Eyetech Pharmaceuticals, Inc. (EYET)
11/10/2005 1:27:37 PM
More...
|
Eyetech Pharmaceuticals, Inc. (EYET) Merger Delayed Over Drug Concerns
11/10/2005 1:19:21 PM
More...
|
Eyetech Pharmaceuticals, Inc. (EYET) Reports Third Quarter 2005 Financial Results
11/1/2005 11:20:39 AM
More...
|
Eyetech Pharmaceuticals, Inc. (EYET) Announces Enrollment Of The First Patient In A Phase 3 Clinical Trial Of Macugen(R) (pegaptanib sodium injection) In Diabetic Macular Edema (DME) And Diabetic Retinopathy
10/19/2005 5:13:22 PM
More...
|
Eyetech Pharmaceuticals (EYET) Announces Co-Founder Marty Glick Steps Down From Board To Act As Consultant
10/19/2005 5:13:14 PM
More...
|
|